Spectranectics CVX-300 Excimer Laser System
Device, angioplasty, laser, coronary. PMA P910001, from Spectranetics Corp. (Colorado Springs, CO). Product code LPC, class 3.
As of Nov 19, 2026, P910001 is an FDA PMA held by Spectranetics Corp., approved on Feb 19, 1993 after 742 days, with no recalls tied to it in FDA's recall database.
- Review time: 742 days
- Supplements: 114
- Recalls: 0
- Cited as a predicate by: 1 device
Approval for the spectranetics cvx-300(TM) excimer laser system, including the models pc1014 and pc1017 laser catheters. This system is indicated for use in patients with single or multivessel coronary artery disease either as a stand alone modality or in conjunction with percutaneous transluminal coronary balloon angioplasty (PTCA) and who are acceptable candidates for coronary artery bypass graft (CABG) surgery. Adjunctive balloon angioplasty was performed, at the clinical investigator's discretion, in 84 percent of the lesions treated. Clinical experience has provided reasonable assurance that the spectraneticics cvx-300(TM) excimer laser system and multifiber laser catheters are safe and effective for the following indications:occluded saphenous vein bypass grafts; ostial lesions; long lesions (greater than 20 mm in length); moderately calcified stenoses (heavily calcified stenoses…
- Excimer Laser Phototherapy System, AL7000K992914 · Acculase, Inc. · Jan 27, 2000
| Aug 21, 2026 | S127Process Change - Manufacturer/Sterilizer/Packager/Supplier | 30-Day Notice |
| Aug 14, 2026 | S126Process Change - Manufacturer/Sterilizer/Packager/Supplier | 135 Review Track For 30-Day Notice |
| Feb 6, 2026 | S124Process Change - Manufacturer/Sterilizer/Packager/Supplier | 135 Review Track For 30-Day Notice |
| Dec 18, 2025 | S125Process Change - Manufacturer/Sterilizer/Packager/Supplier | 30-Day Notice |
| Nov 21, 2024 | S123Change Design/Components/Specifications/Material | Real-Time Process |
| Sep 5, 2024 | S122Process Change - Manufacturer/Sterilizer/Packager/Supplier | 30-Day Notice |
| Oct 30, 2023 | S121Change Design/Components/Specifications/Material | Real-Time Process |
| Aug 31, 2023 | S120Change Design/Components/Specifications/Material | Real-Time Process |
| May 4, 2023 | S119Process Change - Manufacturer/Sterilizer/Packager/Supplier | 30-Day Notice |
| Mar 21, 2023 | S118Process Change - Manufacturer/Sterilizer/Packager/Supplier | 30-Day Notice |
| Oct 21, 2022 | S117Process Change - Manufacturer/Sterilizer/Packager/Supplier | 30-Day Notice |
| Aug 19, 2022 | S116Process Change - Manufacturer/Sterilizer/Packager/Supplier | Real-Time Process |
| May 5, 2022 | S115Change Design/Components/Specifications/Material | Real-Time Process |
| Feb 24, 2022 | S114Process Change - Manufacturer/Sterilizer/Packager/Supplier | Special (Immediate Track) |
| Sep 2, 2021 | S112Change Design/Components/Specifications/Material | Normal 180 Day Track |
- Document
- Approval order (PDF) ↗
- Type
- Original PMA
- Received
- Feb 8, 1991
- Review panel
- Cardiovascular
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files